克服抗生素耐药Helicobacter pylori感染:当前的挑战和新兴的方法
Gabriel Reis Rocha1, Fabian Fellipe Bueno Lemos1, Luis Guilherme de Oliveira Silva1
1Instituto Multidisciplinar em Saúde, Universidade Federal da Bahia, Vitória da Conquista 45029-094, Bahia, Brazil.
World journal of gastroenterology
|March 17, 2025
概括
全球的Helicobacter pylori耐药性正在上升,特别是对克拉里菌素的耐药性. 新的治疗方法和抗生素敏感性测试对于对抗H. pylori耐药性和改善患者的治疗结果至关重要.
科学领域:
- 微生物学 微生物学
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 全球Helicobacter pylori (H. pylori) 耐药性正在增加,在许多地区,克拉里思罗米辛耐药性超过15%.
- 不足够的流行病学监测和非标准化测试方法导致区域差异,并可能低估H. pylori耐药性.
- 杆菌的动态基因组促进了频繁的突变,导致表型耐药性和复杂的治疗策略.
研究的目的:
- 为突出全球范围内H. pylori抗菌素耐药性日益增长的挑战.
- 强调需要改善对H. pylori耐药性的监测和标准化测试.
- 讨论管理H. pylori感染的新兴治疗策略.
主要方法:
- 关于H. pylori耐药性模式的最近研究的综述.
- 对导致H. pylori治疗失败的因素的分析.
- 探索新的治疗方式和支持性疗法.
主要成果:
- 在全球范围内,H. pylori的克拉里素耐药性已超过15%.
- 耐多药H. pylori菌株与一线治疗失败有关.
- 新的治疗方法,包括与竞争的酸阻断剂和益生菌,显示出有前途.
结论:
- 迫切需要加强H. pylori流行病学监测和标准化易感性测试.
- 最佳的初始实证疗法或受敏感性引导的疗法对于防止进一步的耐药性至关重要.
- 新的治疗方法有可能减少抗微生物药物的使用,并提高H. pylori根除率.
相关概念视频
00:57Antibiotic Selection
52.1K
Overview
52.1K
01:31Defense Against Bacterial Pathogens
1.4K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.4K
01:27Combined Effects of Drugs: Synergism
3.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.7K
01:33Bacterial Transformation
55.0K
In 1928, bacteriologist Frederick Griffith worked on a vaccine for pneumonia, which is caused by Streptococcus pneumoniae bacteria. Griffith studied two pneumonia strains in mice: one pathogenic and one non-pathogenic. Only the pathogenic strain killed host mice.
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
55.0K
02:56Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
297
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
297